Research Paper Volume 15, Issue 11 pp 4699—4713
Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
Figure 4. Analysis of association between LPCATs Score and immune infiltrating, potent anticancer inhibitors. (A) The link between LPCATs Score and immune infiltrating score in pan-cancer was illustrated. (B) The value of LPCATs Score in predicating response outcomes and OS in immune checkpoint blockade (ICB) sub-cohorts was demonstrated. (C) The link between gene expression and the sensitivity of GDSC pharmaceuticals (top 30) was represented. (D) The top 30 CTRP pharmaceuticals and their sensitivity to pan-cancer expression profiles are presented.